Contingency Management for Integrated Harm Reduction Among Men Who Have Sex with Men Who Use Methamphetamine in Los Angeles: A Pilot Assessment
- PMID: 36414775
- PMCID: PMC10152513
- DOI: 10.1007/s10461-022-03929-6
Contingency Management for Integrated Harm Reduction Among Men Who Have Sex with Men Who Use Methamphetamine in Los Angeles: A Pilot Assessment
Abstract
Methamphetamine (MA) use is associated with HIV transmission among men who have sex with men (MSM) and lapses in medication adherence. Contingency Management (CM) is effective in reducing MA use, but studies of CM to support adherence to HIV prevention or treatment are limited. We conducted a pilot trial of a CM intervention to reduce MA use and improve PrEP/ART adherence among MSM prescribed a tenofovir (TFV)-based regimen for HIV prevention or treatment. Participants were randomly assigned to receive escalating incentives for either MA abstinence or TFV adherence (based on point-of-care urine testing), and to a monitoring schedule of either 2 or 3 visits/week for 4 weeks. 19 MSM were randomized to either CM for MA use or CM for PrEP/ART adherence (median age: 38; IQR: 28-46) and 15 were living with HIV. Participants attended 95.7% (67/70) of scheduled visits in the 2x/week arm and 74.8% (74/99) in the 3x/week arm. TFV adherence was higher among participants in the TFV adherence arm with 93.5% (n = 72/77) of urine samples positive for TFV, compared to 76.6% (n = 49/64) in the MA abstinence arm (p = 0.007). Participants in the MA abstinence arm had more urine samples negative for MA metabolites (20.3%, n = 13/64) than those receiving CM for TFV adherence (6.5%, n = 5/77; p = 0.021). A CM model for MA abstinence and PrEP/ART adherence using twice-weekly visits and urine testing for MA and TFV for MSM who use MA is feasible and potentially effective as an integrated harm reduction strategy.
Keywords: adherence; contingency management; men who have sex with men; stimulant use; substance use.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Conflict of interest statement
Conflict of interest /Competing interests.
The authors declare that they have no conflict of interest.
Figures
Similar articles
-
Determinants of adherence to daily PrEP measured as intracellular tenofovir diphosphate concentrations over 24 months of follow-up among men who have sex with men.Sex Transm Infect. 2023 Aug;99(5):303-310. doi: 10.1136/sextrans-2022-055499. Epub 2022 Sep 5. Sex Transm Infect. 2023. PMID: 37258273 Free PMC article.
-
Perspectives on the utility and interest in a point-of-care urine tenofovir test for adherence to HIV pre-exposure prophylaxis and antiretroviral therapy: an exploratory qualitative assessment among U.S. clients and providers.AIDS Res Ther. 2020 Aug 6;17(1):50. doi: 10.1186/s12981-020-00308-w. AIDS Res Ther. 2020. PMID: 32762713 Free PMC article.
-
A novel combination HIV prevention strategy: post-exposure prophylaxis with contingency management for substance abuse treatment among methamphetamine-using men who have sex with men.AIDS Patient Care STDS. 2012 Jun;26(6):320-8. doi: 10.1089/apc.2011.0432. AIDS Patient Care STDS. 2012. PMID: 22680280 Free PMC article.
-
High pre-exposure prophylaxis uptake and early adherence among men who have sex with men and transgender women at risk for HIV Infection: the PrEP Brasil demonstration project.J Int AIDS Soc. 2017 Apr 6;20(1):21472. doi: 10.7448/IAS.20.1.21472. J Int AIDS Soc. 2017. PMID: 28418232 Free PMC article.
-
The effectiveness of tenofovir-based pre-exposure prophylaxis for prevention of HIV acquisition among sub-Saharan African women at high risk: a systematic review.Pan Afr Med J. 2021 Mar 26;38:308. doi: 10.11604/pamj.2021.38.308.26014. eCollection 2021. Pan Afr Med J. 2021. PMID: 34178226 Free PMC article.
Cited by
-
Association between homelessness and PrEP uptake among men who have sex with men: Results from the American Men's Internet Survey, 2017-2021.Soc Sci Med. 2025 Feb;366:117674. doi: 10.1016/j.socscimed.2025.117674. Epub 2025 Jan 4. Soc Sci Med. 2025. PMID: 39817941
-
Centering peers in design and training for a peer-delivered contingency management program for self-identified harm reduction and treatment goals.Harm Reduct J. 2025 May 6;22(Suppl 1):72. doi: 10.1186/s12954-025-01213-z. Harm Reduct J. 2025. PMID: 40329274 Free PMC article. Clinical Trial.
-
Managing Stimulant Use Among People With HIV: Harm-Reduction Strategies From Behavior to Medication.Top Antivir Med. 2024 Dec 23;32(5):571-578. Top Antivir Med. 2024. PMID: 39765236 Free PMC article. Review.
-
Point-of-care urine tenofovir monitoring of adherence to drive interventions for HIV treatment and prevention.Expert Rev Mol Diagn. 2024 Mar;24(3):169-175. doi: 10.1080/14737159.2024.2312122. Epub 2024 Feb 14. Expert Rev Mol Diagn. 2024. PMID: 38353417 Free PMC article. Review.
References
-
- Centers for Disease Control and Prevention. HIV infection risk, prevention, and testing behaviors among men who have sex with men - National HIV Behavioral Surveillance, 23 U.S. cities, 2017 2019.
-
- Centers for Disease Control and Prevention. Surveillance Report HIV. 2019. 2021;32.
-
- Halkitis PN, Levy MD, Moreira AD, Ferrusi CN. Crystal methamphetamine use and HIV transmission among gay and bisexual men. Curr Addict Rep. 2014;1(3):206–13.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous